Litfulo (ritlecitinib), a priority brand for Pfizer, is a novel kinase inhibitor that received FDA / EMA approval in 2023 for the treatment of severe Alopecia Areata. Vitiligo, a disease that is the #1 cause of skin depigmentation worldwide, is the next indication in the brand’s pipeline and is expected to be filed in major markets later this year. The Global Litfulo Vitiligo Launch Lead represents the opportunity to lead cross-functional launch readiness and core brand management responsibilities for an expected blockbuster product in Pfizer’s I&I portfolio. This role is responsible for facilitating and leading cross-functional collaboration to ensure launch preparation is completed successfully for all launch markets, in close collaboration with US, ICO, and EMCO (Commercial Organizations). The successful candidate must drive engagement, close alignment, and the brand operating model with cross-indication, cross-functional, and cross-regional teams as well as brand commercial leaders while leading global XFT members on coordinated commercial, medical, and access strategy and tactics. In addition, the Launch Lead is responsible for core brand management activities such as leadership presentation development, operating plan, launch stage gates, cross-functional strategic brand evolution, and life-cycle management analysis. The position will report directly to the Global Commercial Litfulo Vitiligo Lead.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director